http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
C. Massimi,A. Borella,S. Kopecky,C. Lampoudis,P. Schillebeeckx,M. C. Moxon,G. Vannini 한국물리학회 2011 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.59 No.23
Transmission, capture and self-indication measurements on^(197)Au have been performed at the neutron time-of-flightfacility GELINA, operated by the European Commission, at EU-JRC-IRMM inBelgium. Part of this work was performed within the framework of the EFNUDATproject, with the objective to improve resonance parameters for the ^(197)Au(n, γ) cross section. Resonance parameters, i.e.,energy, spin, parity, neutron and radiation width, have been deduced in theenergy domain up to 200 eV. A comparison with results of measurementsperformed at RPI and at n_TOF shows a good agreement betweenthe data sets. In particular the nuclear resonance parameters, of the firsts-wave resonance at 4.9 eV, extracted at RPI are in very good agreement withthe results of the present work.
Ramponi, Laura,Yasui, Youichi,Murawski, Christopher D.,Ferkel, Richard D.,DiGiovanni, Christopher W.,Kerkhoffs, Gino M.M.J.,Calder, James D.F.,Takao, Masato,Vannini, Francesca,Choi, Woo Jin,Lee, Jin W SAGE Publications 2017 AMERICAN JOURNAL OF SPORTS MEDICINE - Vol.45 No.7
<P>Conclusion: An assessment of the currently available data does suggest that BMS may best be reserved for OLT sizes less than 107.4 mm(2) in area and/or 10.2 mm in diameter. Future development in legitimate prognostic size guidelines based on high-quality evidence that correlate with outcomes will surely provide patients with the best potential for successful long-term outcomes.</P>
Tania Coppa,Maria Claudia Lazzè,Ornella Cazzalini,Paola Perucca,Roberto Pizzala,Livia Bianchi,Lucia Anna Stivala,Luca Forti,Cristina Maccario,Vanio Vannini,Monica Savio 한국식품영양과학회 2011 Journal of medicinal food Vol.14 No.10
Resveratrol inhibits endothelin-1, a vascular tension regulator. We synthesized the resveratrol analogue 4,4′-dihydroxy-trans-stilbene with 2 hydroxyl groups in the 4 and 4′ position to obtain a molecule more active than resveratrol (3,4′,5-trihydroxy-trans-stilbene). The results demonstrate that 4,4′-dihydroxy-trans-stilbene led to a significant decrease in total endothelin-1 secretion and in endothelin-1 messenger RNA (mRNA) levels in human endothelial cells. In addition, resveratrol and its analogue decreased endothelin-converting enzyme-1 mRNA levels and further reduced the activity of the enzyme. 4,4′-dihydroxy-trans-stilbene was more active than resveratrol because the new molecule exerted greater activity at the level of endothelin synthesis and conversion, even at a lower concentration. Although 4,4′-dihydroxy-trans-stilbene and resveratrol inhibited formation of reactive oxygen species and lipid peroxidation, the treatment of cells with different oxidant agents did not modify the endothelin-1 release. This finding suggests that the inhibition of endothelin-1 secretion is independent of the antioxidant properties of the 2 compounds. On the basis of these results, the resveratrol analogue 4,4′-dihydroxy-trans-stilbene could be a promising chemopreventive agent against cardiovascular diseases.